1,25-Dihydroxyvitamin D3 enhances the growth of tumors in athymic mice inoculated with receptor rich osteosarcoma cells

This publication has 23 references indexed in Scilit:

• Stimulatory effect of 1α,25-dihydroxyvitamin D3 on the formation of skin tumors in mice treated chronically with 7, 12-dimethylbenz[a]anthracene
  Biochemical and Biophysical Research Communications, 1985
• 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells.
  The Journal of cell biology, 1984
• Enhancement of chemical-carcinogen-induced cell transformation in hamster embryo cells by 1α,25-dihydroxycholecalciferol, the biologically active metabolite of vitamin D₃
  Carcinogenesis: Integrative Cancer Research, 1984
• 1α,25-Dihydroxyvitamin D3 inhibits phorbol ester-dependent chemical carcinogenesis in mouse skin
  Biochemical and Biophysical Research Communications, 1983
• 1,25-dihydroxyvitamin D3 inhibits proliferation of human promyelocytic leukaemia (HL60) cells and induces monocyte-macrophage differentiation in HL60 and normal human bone marrow cells
  Leukemia Research, 1983
• Animal Model of Intracutaneous Melanoma
  Journal of Investigative Dermatology, 1982
• Antitumor effect of 1.ALPHA.-hydroxyvitamin D3.
  The Tohoku Journal of Experimental Medicine, 1982
• An improved radioreceptor assay for 1,25-dihydroxyvitamin D in human plasma
  Analytical Biochemistry, 1981
• 1,25-DIHYDROXYVITAMIN D₃AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTURE
  Endocrinology, 1981
• Basic and Clinical Concepts Related to Vitamin D Metabolism and Action
  New England Journal of Medicine, 1977